Andrew JS Coats

Andrew JS Coats

Director of the Monash Warwick Alliance and Academic Vice-President

Monash University, Australia and University of Warwick, UK

  • LinkedIn
  • Twitter
  • Radcliffe
  • OrcidID

Biography

Prof Andrew Coats is President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK. He is an Australian-British academic cardiologist and inventor. Prof Coats' main interest is heart failure.

From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine of the University of Sydney.

He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor.

Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board. 

 

Read more

Media

Stefan Anker, Andrew JS Coats, Shelley Zieroth, et al

Stefan Anker, Andrew JS Coats, Shelley Zieroth, et al

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Biykem Bozkurt, Andrew JS Coats, Mikhail Kosiborod, et al

Shelley Zieroth, Andrew JS Coats, Javed Butler, et al

Andrew JS Coats, Stefan Anker,

Device Management in HFpEF and HFmrEF: Insights From the REDUCE LAP-HF II Trial

Barry Borlaug, Andrew JS Coats, Gerd Hasenfuß, et al

Andrew JS Coats, Ileana L Piña, Shelley Zieroth, et al

Andrew JS Coats, Ileana L Piña, Shelley Zieroth, et al

Andrew JS Coats, Ileana L Piña, Shelley Zieroth, et al

Andrew JS Coats, Shelley Zieroth, Javed Butler, et al

APSC Journal Club - Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes

Jack Tan Wei Chieh, Jonathan Yap, James Xu , et al

European Heart Failure Guideline Updates: A Peer-to-Peer Discussion on SGLT-2 Inhibitors

Andrew JS Coats, Carolyn Lam,

2021 ESC Clinical Practice Recommendations on the use of SGLT-2 Inhibitors in Heart Failure: An Assessment of their Impact

Andrew JS Coats, Lars H Lund, Michele Senni, et al

A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Andrew JS Coats, Biykem Bozkurt, Carolyn Lam, et al

Andrew JS Coats, Giuseppe Rosano,

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

James L Januzzi, Akshay S Desai, Andrew JS Coats, et al

Andrew JS Coats, Harriette Van Spall, Faiez Zannad, et al

Martin R Cowie, Faiez Zannad, Sanjay Kaul, et al

ESC 2020: Improving Heart Failure Outcomes

Andrew JS Coats,

Juan Carlos Kaski, Giuseppe Rosano, Alexander Lyon, et al

Martin R Cowie, Shelley Zieroth, Nikolaus Marx, et al

Andrew JS Coats, Piotr Ponikowski, Stefan Anker, et al

Past, Present and Future: SGLT2 Inhibitors

Andrew JS Coats, Stefan Anker, John JV McMurray, et al

Past, Present and Future: SGLT2 Inhibitors for Cardiovascular Outcomes - Where are we now?

Andrew JS Coats, Stefan Anker, John JV McMurray, et al

Past, Present and Future: SGLT2 Inhibitors

Andrew JS Coats, Stefan Anker, John JV McMurray, et al

Andrew JS Coats, Faiez Zannad, Stefan Anker, et al

Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitu

Stefan Anker, Andrew JS Coats,

Andrew JS Coats, Carolyn Lam, Felipe Martínez, et al

Uwe Zeymer, Andrew JS Coats, Scott Solomon, et al

Commentary on the ARIADNE trial-Prof Andrew Coats & Prof Scott Solomon

Andrew JS Coats, Scott Solomon,

ESC 2019: Commentary on the PROVE-HF and EVALUATE-HF Studies

Andrew JS Coats, Scott Solomon,

ESC 2019: Commentary on the TRANSITION-CHF and PIONEER-HF Studies

Andrew JS Coats, Scott Solomon,

SGLT2's - Guidelines, Data & Future Practices

Andrew JS Coats, Scott Solomon,

SGLT2's: Current Guidelines, Recent Data & Future Practices

Andrew JS Coats, Scott Solomon,

SGLT2 in HF - Now & the future-Prof Carolyn Lam and Prof Andrew Coats

Carolyn Lam, Andrew JS Coats,

ESC 2019: SGLT2 in HF now and the future

Andrew JS Coats, Carolyn Lam,

Heart Failure 2019 Highlights

Andrew JS Coats,

HFA 2017 Multi-center RCT LV Augmentation with Algisyl HF

Andrew JS Coats,

Andrew JS Coats,

Articles by Andrew JS Coats, Director of the Monash Warwick Alliance and Academic Vice-President

Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly

Ivan Milinkovic, Marija Polovina, Andrew JS Coats, et al

Published:

Citation: Cardiac Failure Review 2022;8:e17.

DOI:

https://doi.org/10.15420/cfr.2021.14
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(2):68–9.

DOI:

https://doi.org/10.15420/cfr.2019.14.1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(3):128–9.

DOI:

https://doi.org/10.15420/cfr.2019.5.3.FO1
Erratum to: Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(1):62.

DOI:

https://doi.org/10.15420/cfr.2018.34.1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2019;5(1):4.

DOI:

https://doi.org/10.15420/cfr.2019.4.1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(1):4–5

DOI:

https://doi.org/10.15420/cfr.2018.4.1.FO1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(2):68-9.

DOI:

https://doi.org/10.15420/cfr.2018.33.1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(2):77–8.

DOI:

https://doi.org/10.15420/cfr.2017:3:2:77
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(1):5–6

DOI:

https://doi.org/10.15420/cfr.2017:3:1:5
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.2.1.6
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(2):78.

DOI:

https://doi.org/10.15420/cfr.2016:2:2:ED1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(2):62-3.

DOI:

https://doi.org/10.15420/cfr.2015.1.2.62
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.01.01.6
The Management of Heart Failure with Preserved Ejection Fraction

Andrew JS Coats, Louise G Shewan,

Citation: Cardiac Failure Review 2015;1(1):11–5

DOI:

https://doi.org/10.15420/CFR.2015.01.01.11